FDA Inspection 1059942 — Inopak Ltd
The FDA completed an inspection of Inopak Ltd on Jul 20, 2018 in Ringwood, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jul 20, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ringwood, NJ (United States)